Early prolonged ambulatory cardiac monitoring in stroke (EPACS): an open-label randomised controlled trial

Summary:

Randomized control trial after TIA or ischemic stroke comparing 14-day Zio XT with short duration Holter for detection of Atrial Fibrillation.

Key Findings:

PAF detection rate was 16.3% with patch-based monitoring vs. only 2.1% with Holter monitoring.

Authors state a 14-day patch could prevent 10.8 additional strokes per year compared to standard Holter-based practice.

The content on iRhythm Academy is provided for general educational purposes only and should not be considered the exclusive source for this type of information. This training does not replace or supersede approved labeling. The content will be shared with physicians and healthcare professionals who seek a deeper understanding of the operation and use of iRhythm products and services with the intent of enhancing their knowledge of features and operations described in the clinician manuals. At all times, it is the professional responsibility of the physicians and healthcare professionals to exercise independent clinical judgment in a particular situation. The device and service functionality and programming described on iRhythm Academy are based on its products and services, and can be referenced in the labeling and reference manuals. This website is intended for healthcare professionals and not intended for patients or consumers.